The company is expanding into large practice markets and investing in the platform: EHR, Billing, RCM, Machine Learning, API software and services
DrChrono Inc., the company developing the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized announced it has raised a $20 million growth capital round from ORIX Growth Capital to spur expansion and increase market share through further investing in the technology platform (EHR, medical billing and API) and expansion of engineering, sales, and support functions.
“The ORIX team has funded some of the best healthcare entrepreneurs and companies in the world. We are extremely excited about this partnership,” said Daniel Kivatinos, Co-Founder and COO of DrChrono. “With our platform and services evolving and maturing, we are in an excellent position to bring the DrChrono platform to larger facilities and specialty practices. Our goal with this additional funding from the ORIX team will be to make the software experience even more amazing, and make critical hires to ensure DrChrono provides the most innovative technology to medical practices.”
DrChrono is growing at a rapid rate. To date, the platform is used by thousands of physicians and has over 17.8 million patients under the care of DrChrono providers. The platform has facilitated the booking of 69 million appointments and the processing of more than $11 billion of medical billing to date.
“After meeting the DrChrono executive team, we were excited about their vision of the future, where healthcare will simply work for physicians and for their patients on a modern platform,” said David Orlandella of ORIX Growth Capital. “Clearly having a modern cloud-based platform is part of the future. We loved the ecosystem of extendible apps that can be layered onto the platform, making it a powerful operating system of any medical practice.”